As of May 22
| -0.001 / -0.29%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 2.26, with a high estimate of 2.26 and a low estimate of 2.26. The median estimate represents a +547.86% increase from the last price of 0.35.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.